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Mechanisms and Effects of Transcranial
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Vincent P. Clark4, H. Branch Coslett5, Michael R. Hamblin6, Roy Hamilton5,
Ryan Jankord7, Walter J. Kozumbo8, R. Andrew McKinley7, Michael A. Nitsche9,
J. Patrick Reilly10, Jessica Richardson11, Rachel Wurzman5,
and Edward Calabrese12
Abstract
The US Air Force Office of Scientific Research convened a meeting of researchers in the fields of neuroscience, psychology,
engineering, and medicine to discuss most pressing issues facing ongoing research in the field of transcranial direct current
stimulation (tDCS) and related techniques. In this study, we present opinions prepared by participants of the meeting, focusing on
the most promising areas of research, immediate and future goals for the field, and the potential for hormesis theory to inform
tDCS research. Scientific, medical, and ethical considerations support the ongoing testing of tDCS in healthy and clinical popu-
lations, provided best protocols are used to maximize safety. Notwithstanding the need for ongoing research, promising appli-
cations include enhancing vigilance/attention in healthy volunteers, which can accelerate training and support learning. Commonly,
tDCS is used as an adjunct to training/rehabilitation tasks with the goal of leftward shift in the learning/treatment effect curves.
Although trials are encouraging, elucidating the basic mechanisms of tDCS will accelerate validation and adoption. To this end,
biomarkers (eg, clinical neuroimaging and findings from animal models) can support hypotheses linking neurobiological
mechanisms and behavioral effects. Dosage can be optimized using computational models of current flow and understanding
dose–response. Both biomarkers and dosimetry should guide individualized interventions with the goal of reducing variability.
Insights from other applied energy domains, including ionizing radiation, transcranial magnetic stimulation, and low-level laser
(light) therapy, can be prudently leveraged.
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Introduction and Background: Brain
Stimulation and Hormesis (Walter J.
Kozumbo)
For a number of years, the US Air Force Office of Scientific
Research (AFOSR) has supported research to elucidate and
engage brain mechanisms that can fortify health and perfor-
mance. Consistent with the recently announced Brain Research
through Advancing Innovative Neurotechnologies initiative,
current efforts have focused upon the development, use, and
assessment of interventional tools and techniques that harness
cutting-edge approaches in bioengineering in synergy with the
biological, chemical, physical, and cognitive sciences. Funda-
mental to this approach is the need for defined outcomes and an
iteratively more detailed understanding of the mechanisms
inherent in these novel approaches.
Current iterations of neurotechnology, including neuromo-
dulatory techniques such as transcranial direct current stimula-
tion (tDCS), show considerable potential as stand-alone
modalities for treating neuropsychiatric disorders and improv-
ing neurocognitive performance. In addition, many of these
techniques can be used in place of or in tandem with other
interventions, including pharmacologic agents, cognitive and
behavioral training, and so on. Ideally, the use of these new
techniques that would enhance the potency of actions and for-
titude of effects allows leftward shifts in dose–response (DR)
curves and reduces burdensome and deleterious side effects of
more traditional treatment approaches.
How various neurotechnologies exert their effects and how
underlying mechanisms can be better understood and exploited
are of principal importance for moving toward integrated treat-
ment approaches. One area of research that may provide a
framework for how to move the field of brain stimulation for-
ward is the field of hormesis. Hormesis is a DR model that
presents an alternative to the two monotonic DR models cur-
rently used in assessing health risks, namely, the linearity no-
threshold (LNT) model and the threshold model.1-3 According
to the LNT model, a toxic response is produced at any dose
level—no matter how small—and is directly proportional to the
dose amount. In the threshold model, toxicity results only from
doses that exceed some threshold value, whereas subthreshold
doses yield no effect at all. As uniquely biphasic, hormesis
serves as an alternative to these two monotonic models. It is
characterized not only by toxic responses to high doses and null
responses to very low doses (similar to the LNT and threshold
models, respectively) but also by stimulatory and (often) salu-
tary responses to doses at levels just below the threshold of
toxicity (see Figure 1).
The scientific literature contains thousands of examples that
demonstrate the stimulatory and beneficial effects induced by
subthreshold doses of various types of toxic agents, including
ionizing radiation, chemicals, light, and even electric currents.
Thus, unlike the LNT and threshold models, the hormetic
model possesses a uniquely stimulatory component that may
prove useful in predicting and explaining the occurrence of
beneficial responses to treatments with electric currents at low,
subthreshold doses, such as are being utilized in the develop-
ment of tDCS and other neurotechnologies.4,5 In the particular
case of tDCS, its DR characteristics are known to be very
similar to those of a typical hormetic stimulus, linking the two
stimulations and suggesting that tDCS is simply another spe-
cific expression of the more generalized phenomenon of horm-
esis. In the case of both tDCS and a typical hormetic stimulus,
the doses are small enough to be considered safe (subtoxic) and
the responses are very frequently (but not always) considered
beneficial. Since beneficial responses in each case are usually
modest in intensity (amplitude) and easily masked by baseline
noise, DR research protocols for both tDCS and a typical hor-
metic stimulus require greater statistical power (larger sample
sizes) and less individual variability among test populations
(greater homogeneity), enhancing sensitivity and, thus,
enabling detection of a modest hormetic response.6,7 Such
similarities in DR characteristics seem to indicate that tDCS-
induced responses are very likely hormetic.
Although initially not very well known and also very con-
troversial, the concept of hormesis has become more broadly
recognized and has gained steady acceptance by the scientific
community. This is due in large part to the research efforts of
Edward Calabrese and his many collaborators at the University
of Massachusetts at Amherst. In the past 20 years, Calabrese
and colleagues have created two hormesis relational databases,
one for ionizing radiation and the other for chemicals (contain-
ing well over 10,000 examples of chemical hormesis) and have
used them to assess and validate various aspects of hormesis.7-9
In over 150 peer-reviewed publications, they have shown that
Figure 1. Schematics of the 3 major toxicological dose–response
models, LNT, threshold, and hormesis, are illustrated above. Toxic
responses to increasing doses of a hypothetical toxicant are repre-
sented as a percentage of untreated controls. Note that the threshold
points for both the threshold and hormetic models are the same
(at dose 5) and that only the hormesis model actually characterizes
the observed reductions in toxicity (beneficial effects) occurring over
a portion of the subthreshold range (ie, between doses 1 and 5).
LNT indicates linearity no-threshold.
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the concept of hormesis applies to many different classes of
stimuli (eg, chemicals, ionizing radiation, heat, pressure, etc),
functions across all plant and animal species and all levels of
bioorganization (from cells to whole organisms), and affects a
broad range of biological end points. Statistical analytical stud-
ies conservatively argue that at least 40% of all chemicals are
hormetic and that the true default DR model is in fact horm-
esis.10-14 Qualitative and quantitative assessments indicate that
the optimal hormetic dose for toxic agents occurs at a low dose
range and is always below the toxicity threshold.3 Mechanisms
have been documented for hundreds of hormetic responses,3
and a modern popular toxicology textbook now references and
describes hormesis as a legitimate alternative to current DR
models.15 Moreover, Calabrese has recently shown16,17 that
adaptive and preconditioning responses, which are readily
accepted and broadly utilized by the scientific and medical
communities because of their great promise in the treatment
and prevention of diseases, are simply manifestations of horm-
esis. This important finding underscores hormesis as a founda-
tional concept in understanding DR phenomena, lends greater
credence to the authenticity and utility of the hormetic model,
and, most importantly, strongly suggests exploiting hormesis
(and knowledge of its stimulatory phase) for the purpose of
developing various novel interventions, such as tDCS, for use
in the cure and prevention of physical and mental diseases, as
well as in the enhancement of normal cognitive functions.
Low levels of ionizing radiation are also known to stimulate
beneficial (hormetic) responses,18 suggesting the possibility
that low levels of nonionizing radiation, such as light, radio-
frequency radiation, and electromagnetic fields, may evoke
similar beneficial (hormetic) responses. Indeed, evidence is
now appearing in the literature supporting the idea that non-
ionizing radiation at low doses can modulate biological
responses in cells.19-23 In view of this exciting possibility, and
the fact that hormesis has now been authenticated for chemicals
and ionizing radiation, the AFOSR has initiated new research
to explore the possible hormetic effects of nonionizing radia-
tion. This research includes (1) the development of a relational
database at the University of Massachusetts on nonionizing
radiation-induced hormesis and (2) animal and human investi-
gations at the Air Force Research Laboratory24,25 to explore the
behavioral and cognitive effects induced by one specific form
of nonionizing radiation, transcranial electrical stimulation
(tES). As tES can be administered to the brain as either an
alternating, oscillating, or direct electrical current, the Air
Force has chosen to utilize direct current in its initial research
efforts since to date most of the fundamental and applied
research in the tES area has been conducted using tDCS
technology.6
Transcranial direct current stimulation has been used to
investigate the effects of low doses of electrical currents on
modulating behavior, cognition, and performance in animals
and humans and on the molecular and cellular mechanisms by
which these effects may be mediated. The effects of tDCS on
improving learning26-29 and memory30-32 and on mitigating
depression,33,34 chronic pain,35,36 fatigue,37 are of immediate
interest to the Air Force. In addition, tDCS has also been
reported to improve stroke recovery times38,39 and symptoms
of a number of psychiatric disorders,40,41 suggesting the further
possibility that military-related neuropsychiatric pathologies,
such as post-traumatic stress disorders and traumatic brain inju-
ries, may offer other opportunities to apply tDCS technology.
Toward Elucidation of Mechanisms: Key
Questions
Most experimental research in the area of tDCS currently
focuses on behavioral effects and, as such, tends not to address
the neural mechanisms involved in mediating these effects. In
view of this gap in understanding, the primary goal of the Air
Force planning meeting was to develop a research strategy that
will help to elucidate the fundamental cellular and molecular
mechanisms involved in tDCS. That tDCS appears to be non-
toxic and yet optimally effective at negligibly small current
strengths (1-2 mA) strongly suggests a possible hormetic
mechanism. As a result, the knowledge acquired from the
expanding hormesis databases offers opportunities to generate
insights, hypotheses, and guidance for expanding our under-
standing of the cellular and subcellular mechanisms of tDCS.
Specifically, the hormesis model suggests that future tDCS
research could benefit by identifying (1) the optimal stimula-
tory dose for each individual (including frequency, intensity,
duration, pulse characteristics, etc), (2) the specific brain sites
(and networks) to be targeted to evoke the desired response,
and (3) the specific cellular components that mediate the
response. Adopting these research suggestions would imply the
need to develop biomarkers for use in determining the optimal
tDCS treatment dose on an individual basis and a technique/
device for accurately delivering a measured dose to a specific
area of the brain.
Ultimately, the vision and hope are that tDCS research—
enabled by hormesis—will produce acceptable, noninvasive,
safe, quick-acting, and long-lasting treatments and/or optimi-
zations of neurocognitive and behavioral functions that, unlike
pharmacological agents, can target specific tissues and neural
networks with minimal or no deleterious side effects.
To help advance discussion relevant to the goals of the Air
Force planning meeting, the following questions were used to
prompt and guide discussions:
1. What is the current state of knowledge concerning
tDCS?
2. What new knowledge will advance mechanistic under-
standing of tDCS?
3. What barriers are preventing acquisition of this new
knowledge?
4. How can these barriers be overcome or eliminated?
5. What role(s) can theoretical modeling play in under-
standing mechanisms?
6. How are theoretical and experimental approaches inte-
grated, and how should such integration be fortified in
future studies?
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7. What equipment and personnel needs are necessary to
realize such integration?
8. How are dosimetry requirements determined?
Putative Mechanisms of tDCS (Marom
Bikson, Michael Nitsche)
Over the past 15 years, animal and human studies of basic
mechanisms of tDCS42 have identified some major physiolo-
gical effects, such as subthreshold polarization of neuronal
membranes43,44 and glutamatergic plasticity. Such effects
involve spontaneous neuronal activity adjunct to DC-induced
membrane polarization45,46 and regional plasticity effects on
cerebral networks.47,48
The rigor of these experiments has established a basis for
designing interventional strategies to enhance learning and per-
formance and to treat neuropsychiatric disorders. Many clinical
trials are based on dose parameters (1-2 mA, 20-30 minutes) that
have been shown experimentally to produce lasting changes in
brain excitability. These same clinical neurophysiology studies
have shown a nontrivial DR function and interactions with
ongoing tasks and chemical agents.49-51 Based on experimental
data, theories have been advanced to explain tDCS mechanisms,
although we currently lack an explanatory framework that has
been accepted by the tDCS research community. In fact, a
majority of trials with tDCS are rationalized simply by placing
the electrode ‘‘over’’ a target region and assuming based on the
polarity of the electrode (anode or cathode) that ‘‘brain function’’
will be altered (boosted or inhibited). This rationale ignores the
complexity of tDCS dose, issues regarding the physics of brain
current flow,52 complex relations between cortical activity and
performance, and treats higher cognitive function and disease as
a ‘‘sliding scale’’ rooted in 1 brain region.
There remains a gap between data collected on tDCS
mechanisms in animals and humans45,53,54 and the development
of a comprehensive mechanistic framework that explains how
tDCS can be optimized (eg dose, high-definition tDCS)55 for a
given indication or individual.56 Reliable methods to predict and
correct for interindividual differences are lacking.57,58
Clinical trials (using a range of doses) should be part of an
ongoing effort to collect data for a mechanistic model.59,60
Central to this endeavor are (1) new tools (biomarkers) to
measure and titrate the effects of tDCS in both animals and
humans,61,62 (2) a framework to relate findings on neurophy-
siological responses to tDCS to cognitive functions and beha-
viors, and (3) definition of optimal practices that would
ensure reproducibility of tDCS-induced effects in both
research and translational (clinical and/or paraclinical, eg,
occupational) use.63-65
Types of Stimulation (Michael R. Hamblin,
Michael Nitsche)
A variety of brain stimulation methods can be derived, which
differ in regard to the physical properties of the induction
procedure. The term ‘‘noninvasive’’ brain stimulation refers to
those techniques that act on brain physiology without the need
for surgical procedures involving electrode implantation (such as
deep brain, direct cortical, or epidural stimulation techniques).
The main group of noninvasive stimulation techniques affects
brain function via electrical or magnetic impulses. However,
laser stimulation, transcranial ultrasound, and tonic magnetic
fields have also been shown to affect brain physiology.
Conventionally, stimulation techniques that primarily
induce activity of neurons (suprathreshold stimulation) are dis-
tinguished from those that primarily exert modulatory effects
on ongoing neuronal activity and excitability (subthreshold).
The first group includes high-intensity short-pulse tES, tran-
scranial magnetic stimulation (TMS), electroconvulsive ther-
apy, and paired associative stimulation (PAS). The second
group includes forms of low-intensity (eg, few mA) and sus-
tained (eg, minutes) tES, such as tDCS, transcranial alternating
current stimulation (tACS), and transcranial random noise sti-
mulation (tRNS). The electric field intensities produced in the
brain by suprathreshold techniques are often 2 orders of mag-
nitude above subthreshold,52,66-70 allowing for triggering of
action potentials.71 However, it is important to recognize that
so-called suprathreshold techniques ultimately affect behavior
by modulation of endogenous networks,72,73 whereas the so-
called subthreshold techniques can influence firing in the active
system.74 For a comprehensive classification of tES tech-
niques, see Guleyupoglu et al.75
Transcranial electrical stimulation using high-intensity
short pulses was introduced in 1980 and was the first non-
invasive brain stimulation technique shown to alter activity
in the human cerebral cortex.76 An electrical stimulus
between 300 and about 1000 V is applied for a few milli-
seconds via the intact skin over the target region. Suffi-
ciently strong stimulation results in the activation of
neurons in the target area. One disadvantage of this stimula-
tion technique is that it also activates excitable structures in
the skin between the electrodes and the target, and thus, this
stimulation is relatively painful.
This problem is circumvented by the use of TMS, which
induces electrical current flow in the brain via magnetic induc-
tion based on Faraday law, delivered through a magnetic coil
placed on the head.77 This procedure is relatively painless in
comparison. Recently, more sophisticated stimulation proto-
cols have been developed, which allow relatively selective
activation of pharmacologically characterized neuronal subpo-
pulations, such as glutamatergic, GABAergic, and cholinergic
neurons.78,79 Beyond these stimulation protocols that induce
solely acute activation of target neurons, stimulation protocols
have been developed which result in alterations in cortical
excitability that outlast the stimulation (ie, to induce neuroplas-
ticity). One of these techniques is repetitive TMS (rTMS), in
which trains of magnetic stimuli induce long-term potentiation
(LTP)– or depression-like alterations in neuronal excitability.
Similar to animal experiments, slow stimulation (stimulation
frequency  1 Hz) induces excitability diminutions, whereas
high-frequency stimulation (>1 Hz) induces excitability
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enhancements. Recently, new stimulation techniques such as y-
burst stimulation or quadripulse stimulation have been devel-
oped, which are aimed to induce more stable and longer-lasting
effects.80
A qualitatively different protocol is PAS. In this study, a
peripheral nerve stimulus is combined with a central nervous
system stimulus. The standard protocol encompasses motor
cortex plasticity induction via a combination of motor cortex
TMS and stimulation of a peripheral nerve of the upper limb.
Dependent on synchronous or asynchronous arrival of both
stimuli the targeted motor cortex, LTP-like (synchronous) or
LTD-like (asynchronous) plasticity is induced, which share
some aspects with spike-timing-dependent plasticity and has
been well explored in animal experiments.
Tonic stimulation with direct currents (eg, tDCS) can be
discerned from oscillatory stimulation techniques (eg, tACS,
tRNS). All of these stimulation techniques encompass position-
ing at least 2 stimulation electrodes on the body; for brain
stimulation protocols, at least one of the electrodes is placed
on the head. Generally, electrodes are relatively large (between
25 and 35 cm2), and stimulation intensity varies between 1 and
3 mA.81 However, new protocols that encompass more focal
(eg, high-definition tDCS) or network stimulation by use of
multiple target electrodes are available.52,82 The direction of
respective activity and alterations in excitability depend on the
direction of electrical current flow in relation to neuronal orien-
tation. The use of tRNS with frequencies between 100 and 600
Hz induces similar neuroplastic effects, in which direction
depends on stimulation intensity.83 To date, it remains unclear
whether tRNS alters oscillatory brain activity. Alteration in
spontaneous oscillatory activity can be accomplished through
tACS, which in the main frequency bands of physiological
brain activity does not induce plasticity. However, stimulation
in frequency bands above 100 Hz up to low kHz frequencies
has been shown to induce LTP-like plasticity.84
Transcranial near-infrared (tNIR) light therapy is a rela-
tively new approach for treating brain disorders and possibly
for enhancing cognitive function.85 It is derived from low-level
laser (light) therapy (LLLT, also known as photobiomodula-
tion), which has been studied since 1967 (see Chung et al86 for
a review). Low-level laser (light) therapy has been mostly used
to stimulate wound healing, to reduce pain and inflammation,
and to preserve tissue at risk of necrosis. The mechanism of
action of LLLT is thought to involve absorption of red or near-
infrared photons by cytochrome C oxidase (unit IV of the
mitochondrial respiratory chain).87,88 This photon absorption
may dissociate inhibitory nitric oxide,89 thereby allowing
respiration to resume unhindered and adenosine triphosphate
(ATP) synthesis to increase.90 Various signaling molecules are
activated, including (but not limited to) reactive oxygen spe-
cies, cyclic adenosine monophosphate (cAMP), nitric oxide
(NO), and calcium (see Figure 2; Alexandratou et al91).
Retrograde mitochondrial signaling may also play a major
role in the response to light.92 Many transcription factors have
been shown to be activated and have been proposed to account
for the long-lasting effects of light exposure.20 Recently, light-
sensitive ion channels such as the transient receptor potential
vanilloid channel have been suggested to be involved in cellu-
lar mechanisms of LLLT action.93
The use of tNIR as an intervention started with studies
using LLLT after induction of stroke in animal models.94
Promising results in 2 different animal models (rats and
rabbits) led to a series of clinical trials.95 The first trial was
Figure 2. Mechanism of action of LLLT at a cellular level. Near-
infrared (NIR) light is absorbed in mitochondria, leading to the activa-
tion of signaling pathways (cyclic adenosine monophosphate [cAMP],
reactive oxygen species [ROS], NO) that in turn activate transcription
factors such as nuclear factor kappa B (NF-kB) and activator protein 1
(AP1) (see text for details). LLLT indicates low-level laser (light) ther-
apy; NIR, near-infrared; ROS reactive oxygen species.
Figure 3. Mechanism of action of tNIR in the brain. The transcription
factor activation as discussed in Figure 1 leads to upregulation of
neurotrophins such as BDNF leading to neuroplasticity (synaptogenesis)
and newly formed neurons (neurogenesis). Neuroinflammation is
reduced. BDNF indicates brain derived neurotropic factor; IL-1, inter-
leukin 1; NGF, nerve growth factor; TNF-a, tumor necrotic factor a;
tNIR, transcranial near-infrared.
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successful,96 the second had mixed success,97 whereas the
third trial failed to meet its interim end point and was there-
fore discontinued for futility.98 Nevertheless, the relative suc-
cess of at least some of these studies prompted researchers’
continued investigations of the effects of LLLT in acute TBI
in animal models.99 From such work, a number of positive
results have now been reported. There is building evidence to
support that tNIR can stimulate neurogenesis as shown by
induction of bromodeoxyuridine (BrdU)-positive neuropro-
genitor cells in the dentate gyrus and subventricular zone of
laboratory animals.100 Moreover, tNIR can stimulate synapto-
genesis or neuroplasticity as shown by upregulation of synapsin-
1 in the cortex of mice with TBI (see Figure 3; Xuan et al101).
The use of tNIR is currently being studied as a possible
approach to treating neurodegenerative disorders such as Alz-
heimer dementia102 and Parkinson disease,103 and clinical stud-
ies are currently underway that examine the potential for using
tNIR to treat psychiatric disorders such as major depression104
and cognitive and emotional effects of TBI.105
Yet, it may be premature to consider tNIR as a form of
noninvasive brain stimulation in the same way as described for
tDCS and rTMS. There appears to be both several similarities
as well as several differences between these approaches. Simi-
larities include the fact that tNIR and tDCS and rTMS have
been used for cognitive enhancement in normal (nondiseased)
subjects. Transcranial near-infrared has been used to improve
memory in mice106 and improve cognitive function107 and
mood108 in healthy human volunteers. Both LLLT19,109 and
tDCS110 techniques appear to exert hormetic effects.111 Such
hormetic effects were shown in a recent study of tNIR for TBI
in mice: 3 daily LLLT treatments were shown to produce better
outcomes in terms of neurological severity score and Morris
water maze performance than either a single treatment (4 hours
post-TBI) or 14 daily LLLT treatments (1 a day for 2 weeks
post-TBI).112 As previously noted, tNIR can stimulate brain-
derived neurotrophic factor (BDNF) and synaptogenesis in
mice,101 but the effect was most pronounced at a long time
point (4 weeks) post-tNIR treatment.
Differences between LLLT and tDCS include the fact that
there is little evidence to date that tNIR produces direct neural
activity. To our knowledge, there have not been any studies that
have shown that tNIR induces LTP or LTD in ex vivo brain slices.
It is clear that tDCS- and rTMS-induced cognitive enhancement
has been studied much more than the same effects produced by
tNIR. Yet, we believe that it is fair to say that the mechanism of
action of tNIR is better understood than the mechanism that may
putatively be involved in the effects of tDCS. Clearly, further
research will be required to better elucidate the mechanisms and
relative effectiveness of these approaches in producing defined
neurocognitive and behavioral outcomes.
Animal Models (Ryan Jankord, Marom
Bikson)
As previously noted, it is not in any way a novel idea that neural
activity can be modulated by an externally applied electrical
field. It was almost 60 years ago that Terzuolo and Bullock113
used the abdominal receptors in the crayfish and the cardiac
ganglion of the lobster to study neural modulation by an elec-
tric field. From their observations, these authors concluded that
(1) active neurons are sensitive to small electric fields; (2) a
static electrical field can modify the frequency of neural firing;
(3) higher electric fields are required to cause a silent neuron to
fire than to modulate the function of an active neuron; (4) the
orientation of electric field relative to neuronal morphology
(axis of polarization) determines whether firing is accelerated
or inhibited; and (5) there is an optimal axis of polarization, and
rotation of this axis changes the amount of electric field
required to induce a similar response. These results were
among the first to demonstrate that electrical stimulation can
have immediate and profound effects on neural activity and
established the foundation for subsequent studies that investi-
gated these factors.43,114,115
In addition to the immediate effects of electrical stimulation,
Bindman et al116 demonstrated that a polarizing current delivered
for at least 5 minutes resulted in long-lasting changes in evoked
and spontaneous activity that continued for several hours. These
authors noted that ‘‘ . . . it is possible to produce a long-lasting
change in the activity of the brain by means of a very small
temporary alteration in the physical environment of the nerve
cells.’’ These early experiments demonstrated that electrical
simulation has both immediate effects on neuronal activity and
can also induce effects that persist beyond the cessation of elec-
trical stimulation. The requirement for sustained (eg, on the order
of minutes) stimulation to produce lasting changes informed the
studies of Nitsche and Paulus117 and prompted modern tDCS
protocols to continue to employ sustained stimulation.
Many studies subsequent to Terzuolo and Bindman’s work
have contributed to the current understanding of how neural
function can be modulated by extrinsic stimuli. One area of
particular relevance is the study of LTP,118 a mechanism by
which tDCS is thought to modulate brain function. Studies of
rodent brain slices in vitro have demonstrated that direct cur-
rent stimulation can affect LTP53 and that the effect of stimula-
tion on LTP was dependent on N-methyl D-aspartate and
BDNF.45 More recent studies in rabbits have shown that tDCS
may modulate presynaptic mechanisms of transmission.119 In
addition, sustained direct current has also been shown to pro-
duce acute and lasting changes in oscillations in brain slices.54
Thus, it will be important for animal studies to further charac-
terize molecular mechanisms underlying tDCS-induced LTP
and specifically address how low-intensity stimulation is
amplified and why sustained currents are needed.
One of the many advantages of animal models is that beha-
vioral changes can be both correlated with underlying neurobio-
logical mechanisms and translated to clinical populations. For
example, it has been shown that the application of tDCS over the
frontal cortex improves working memory and skill learning in
rodent models.120 Furthermore, tDCS exerts beneficial effects on
neural plasticity and motor function in rodent models of stroke
injury, suggesting an influence upon both neural structure and
function.121 In a rat model of cognitive dysfunction, tDCS has
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also been shown to promote the recovery of motor behavior.122
These studies reveal considerable modulatory effects of tDCS
and raise the possibility that tDCS may have the potential to
provide therapeutic benefits in a number of neuropsychiatric
conditions, as well as to improve performance in a variety of
neurocognitive and behavioral tasks.
Effects of tDCS on Cognitive Function and
Performance (R. Andrew McKinley, James
Giordano)
There is a growing body of literature suggesting that noninvasive
brain stimulation techniques, including certain types of tES (eg,
tDCS and/or tACS), can modulate brain activity in ways that
benefit aspects of cognition that are directly related to learning,
acquisition, and performance123-125 (see McKinley et al126 for
review). A number of career fields require human operators to
engage and/or monitor manual and highly automated systems.
Repetitive tasks and those that require sustained vigilance and
attention demand considerable effort to maintain over long peri-
ods of time. Humans are not particularly skilled at maintaining
long-term vigilance. In fact, a phenomenon known as the ‘‘vig-
ilance decrement,’’ which is characterized by a linear decrease in
the number of critical signals recognized over time or an
increase in reaction time,127 has been well documented in the
literature since the 1960s.128 Depending on the frequency of the
visual stimulus and the target stimulus, this decrement can be
observed in as little as 20 minutes.129 This tendency to miss a
greater number of critical signals or targets over time can have
profound consequences in both civilian and military professions
that need to maintain high levels of vigilance over long periods
of times to protect human lives from potential danger (eg, air
traffic control operators, security personnel, intelligence ana-
lysts, baggage screeners, etc).
Recent findings support that tDCS may be well suited to miti-
gating decline in human cognitive capacities necessary for the
performance of tasks requiring sustained attention. Nelson
et al130 provided evidence that tDCS applied over either the left
or right dorsolateral prefrontal cortex (DLPFC) eliminated the vig-
ilance decrement in a 40-minute task trial. Vigilance decrement is
typically accompanied by a linear decline in blood flow velocities
within either the left or right middle cerebral artery.129 Nelson
et al130 indicated that tDCS attenuated this decline in blood flow
velocity and increased regional cerebral oxygen saturation.
Moving the anode location from the scalp site directly over
left DLPFC to a more caudal location (ie, over the left frontal
eye field) produced similar effects on vigilance perfor-
mance.131 This study also presented evidence that tDCS pro-
duced changes in oculometrics, such as eye blink rate and
percentage of eye closure. The authors concluded that these
changes were indicative of more eye movements and hence
reflected subjects’ more thorough searching of (ie, increased
attentiveness to) the visual scene.
The improvements in attention and visual search have more
recently been shown to enhance multitasking performance.132
The data suggested that tDCS led to a significant increase in
information throughput (ie the amount of stimuli to which the
participant could respond) over the entire range of difficulty
levels tested. When examining performance in the individual
tasks, the tasks that tested attention/vigilance were enhanced to
the greatest extent. Tasks such as tracking and audio commu-
nications did not exhibit a large effect. Thus, the results help
reinforce the idea that tDCS applied over the left DLPFC pre-
ferentially affects sustained attention.
The effects of tDCS on vigilance have also been observed on
much longer time lines in sleep-deprived research participants.
Using the tDCS paradigm of Nelson et al,132 McIntire and cow-
orkers37 demonstrated that tDCS mitigated the vigilance decre-
ment for at least 6 hours—3 times longer than the effect of
caffeine. Additionally, both tDCS and caffeine led to improve-
ments in reaction time and fewer lapses on a simple reaction time
task, both of which are highly sensitive to fatigue. Subjective
reports revealed that participants receiving tDCS experienced
less fatigue and/or drowsiness and more energy following sti-
mulation as compared to subjects who received sham tDCS. A
follow-on study examined these effects when tDCS was applied
10 hours earlier in the sleep deprivation period.133 The results
confirmed that tDCS prevents declines in vigilance performance
for approximately 6 hours poststimulation. However, the effects
on arousal and mood were found to persist much longer (at least
24 hours post-tDCS). These findings suggest that it may be
possible to administer tDCS before the start of the shift to pro-
vide performance benefits that last the duration of the shift.
Transcranial stimulation-induced changes in attention are also
believed to influence learning. Clark et al134 found that anodal
tDCS applied on a scalp location over the right ventral lateral
cortex facilitated training in a threat detection task. Participants
were asked to identify threats such as trip wires and sniper sha-
dows in simulated combat theater (ie, dismounted soldier) set-
tings. These findings, later replicated by Falcone et al,135 revealed
that improvements in threat detection performance persisted for at
least 24 hours following tDCS. McKinley et al,29 using the same
tDCS montage employed by Clark and colleagues,134 demon-
strated facilitated learning in a threat detection task involving
identification of threats in simulated synthetic aperture radar ima-
gery. Both Clark et al134 and McKinley et al29 posited that tDCS
may modulate attention during training, thereby improving learn-
ing. Simply put, the more information that can be attended to
during training, the more that can be encoded and subsequently
remembered. However, information that is focal to attention is not
necessarily engaged in/by processes of memory.136,137 Proce-
dural memory has also been shown to benefit from tDCS applied
to the left DLPFC.138
Participants were trained to identify targets as ‘‘friends’’ or
‘‘foe’’ in a gaming simulation called ‘‘Warship Commander,’’
which was developed by the US Navy. The task requires parti-
cipants to learn a series of button presses that must be per-
formed quickly and in the correct order to maximize their
score. Participants who received cathodal tDCS over the left
DLPFC during memory consolidation (ie, immediately after
training) performed significantly better 24 hours later than
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subjects who received either sham tDCS or anodal tDCS over
the motor cortex during training. Nondeclarative and declara-
tive memory systems are competitively interactive139,140;
therefore, it is believed that cathodal tDCS reduced activity
in brain networks typically engaged in declarative memory
(ie left DLPFC). This, in turn, disinhibited procedural memory
systems during the consolidation process.
Cognitive performance effects of tES are highly context
dependent.141,142 Individual traits (eg, age, gender, hormonal
levels, brain state and network excitability, and/or inhibitory
tone), as well as specific aspects of environment and task(s), all
affect and can alter response to noninvasive neuromodula-
tion.50,51,143,144 This is crucial to note when considering how
tES may (a) be dependent upon brain state for effect; (b) dif-
ferentially affect neural nodes and networks active in learning,
memory, vigilance, and attention; and (c) be utilized and
employed in practical settings to facilitate and optimize these
cognitive and behavioral functions.
Understanding how tES engages and affects neural function
is important to the development of improved methods. A num-
ber of putative mechanisms of tDCS-induced changes in beha-
vior and performance have been proposed. It has been posited
that anodal tDCS affects cerebral metabolic activity, based
upon studies that have shown increased glutamate, glutamine,
and N-acetyl aspartate (NAA) levels produced in parietal cor-
tical loci both proximal and contralateral to application of 2.0
mA tDCS (30-minute treatment).145 Nonlocal, more global
cerebral effects have also been described.146 Because the tDCS
paradigms described by McKinley et al,29 Nelson et al,130,132
and McIntire et al37 used an extracephalic cathode placement
on the contralateral biceps, it is possible and even likely that the
applied current either incurred a peripheral to central effect
and/or modulated activity in areas of the brain stem, including
the reticular magnocellular nuclei, thereby inducing increased
supraspinal noradrenergic activity. It has been speculated that
glutamatergic–noradrenergic interactions (ie, glutamate ampli-
fication of noradrenergic effects) may be involved in eliciting
cortical ‘‘hot spots’’ that represent increased nodal and network
functions important to attention, learning, and memory.147 It is
also possible that neuromodulatory effects involve activation
of glial mechanisms.
Application of tDCS over the right motor cortex caused a
significant increase in fractional anisotropy (FA) in the right
inferior longitudinal fasciculus and right internal capsule lying
beneath the anode. The change in FA was due to alteration in
radial, but not axial, diffusivity. This change in FA was likely
caused by modification of white matter (ie, a change in mye-
lination). Increased myelination would potentially improve
efficiency of signal transmission within and between nodes in
neural networks148 (a more detailed discussion of putative
mechanisms of tES is provided elsewhere in this paper).
In sum, the aforementioned studies suggest a promising role
of tES in human performance optimization. Further research
will be required to more accurately define how individual and
environmental variables interact to affect the outcome(s), via-
bility, and value of specific neuromodulatory approaches.
Clinical Applications of tDCS and the
Importance of Elucidating Mechanisms
(Roy Hamilton, Vincent P. Clark)
Recent years have seen an explosion of interest in clinical appli-
cations of tDCS, including but not limited to the fields of neu-
rology, psychiatry, physiatry, and pain management.42 The
practical advantages of using tDCS as a therapy are readily
apparent—it appears to be safe and is tolerable, inexpensive,
relatively simple to operate, and easy to combine with other
treatments. For these reasons, it is being investigated as both a
replacement therapy for pharmacologic and other treatments
that are intolerable, ineffective, unavailable, or prohibitively
expensive and as an adjunctive approach to enhance the efficacy
of existing medications and behavioral therapies. For example,
recent meta-analyses have shown that active tDCS was effective
in reducing major depression when compared to sham tDCS,149
for reducing neuropathic pain after spinal cord injury150 and also
for improving cognition in age-related dementia.151
However, as more of this work emerges, it is becoming
increasingly clear that improved understanding of the basic
mechanisms of tDCS is needed in order to truly advance its
use in clinical populations, as well as to ensure its long-term
safety. Other meta-analyses have shown small or inconsistent
effects or a lack of significant effect for other clinical popula-
tions, such as for certain aspects of recovery from stroke.152,153
Such failures may have resulted from uncertainty regarding the
mechanisms of tDCS. In the absence of this type of knowledge,
two fundamental therapeutic questions will remain largely
unanswered—What is the most effective way to stimulate the
brain with tDCS? and What are the most likely intended and
unintended outcomes of stimulation?
It is widely understood that a variety of stimulation para-
meters dictate the behavioral effects of tDCS, including but not
limited to electrode number, location, size, and polarity, as well
as stimulation intensity and duration.154 For cognitive func-
tions, recent evidence also suggests that the task one is engaged
in during tDCS significantly impacts the effects of stimula-
tion.50 To a first degree of approximation, these parameters
align conceptually with known cellular and interneuronal
mechanisms of tDCS. For instance, the depolarizing effects
of anodal tDCS on neuronal resting membrane potentials71 and
its demonstrated influence on LTP in neuronal circuits53 pro-
vide some account for the observed excitatory effects of anodal
stimulation on motor physiology and behavior. However, fur-
ther exploration of these parameters reveals important gaps in
our understanding of tDCS mechanisms. For instance, the
effects of stimulation do not follow simple linear DR relation-
ships.49 Moreover, anodal and cathodal stimulation are not
synonymous with excitatory and inhibitory stimulation with
respect to their effects on neural function and behavior.49,155
In short, our current understanding of tDCS effects at the level
of the cell does not map neatly onto complex behaviors, under-
scoring the need for better characterization of the principles
and properties that govern functional relationships at the level
of the cell, circuit, network, and system.
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This process of characterization will also permit clearer
predictions of which individuals are likely to benefit from
stimulation, which disease processes are likely to be most amen-
able to treatment, and what some of the long-term intended and
unintended consequences of stimulation are likely to be. The
latter issue is especially relevant when considering how appli-
cations of tDCS in clinical populations are likely to be used to
inform potential interventions to enhance performance in other-
wise healthy populations. Evidence suggests that stimulation
applied with either inadequately considered parameters or
to the wrong population(s) of individuals could result in inad-
vertent deleterious effects on cognition and performance, at
least acutely under experimental conditions.51 Research that
allows a more thorough, finely granular understanding of the
biological and neural effects of tDCS will allow better prediction
and monitoring of undesired cognitive and functional effects
that may arise from stimulation, and will help to prevent or at
least minimize potential deleterious cognitive effects.
In conclusion, clinical investigations employing tDCS
have undergone tremendous expansion in recent years and are
producing some promising results for certain clinical popula-
tions. However, the effectiveness and utility of this technol-
ogy in the clinical arena are ultimately constrained by
limitations in understanding of its basic mechanisms. Perhaps,
in light of this paucity of mechanistic understanding, few
clinicians employ tDCS in clinical practice, and the limited
number of clinicians who do tend to rely on reductive and
oversimplified concepts to guide how stimulation should be
applied and to whom. Thus, many patients are unable to
access tDCS in clinical care. To some extent, this has fostered
a ‘‘do-it-yourself’’ movement among prospective patients
(and more broadly within the general population, with goals
of cognitive performance optimization), which has become
the subject of considerable attention and some concern.156
Clearly, this is a field in which further mechanistic discov-
eries at the bench will translate into important advances and
refinements at the bedside and possibly beyond.
Roles of DR and Hormesis Concepts
in Elucidating Mechanisms of tDCS
(Edward Calabrese, H. Branch Coslett,
Rachel Wurzman)
As noted, there is an urgent but as yet unmet need for additional
and ever more detailed information regarding parameters of
tDCS. Lack of such information (eg, about optimal current inten-
sity and duration) has delayed the advancement of theoretical and
experimental foundations of research into the mechanisms of
action of tDCS and, ultimately, the translation of tDCS to use in
clinical and occupational settings. Dose–response relationships
for tDCS have been difficult to identify for a number of reasons.
First, in the case of tDCS, dose is not a simple measure.
Instead, tDCS dose is defined by multiple factors, including
current strength, electrode size, stimulation site, polarity, dura-
tion of stimulation per session, and frequency and number of
sessions. Interactions among these variables are likely to be
complex and unequally relevant for different tDCS mechan-
isms investigated. For example, the duration of stimulation is
the factor most relevant to the DR relationship model.157
Hormesis therefore has the advantage of being a generalizable
model for relating tDCS dose to response for multiple mechan-
isms located across many different levels of brain organization,
which could prove especially valuable for the development of
predictive DR models needed to advance the field.
Second, tDCS influences the nervous system at multiple
levels and possibly at multiple timescales. Unlike pharmacolo-
gical agents in which the response of brain network activity can
be considered downstream of effects at the cellular and sub-
cellular levels (eg, through receptors that mediate changes in
cell membrane excitability or gene expression), the physical
effects of tDCS (eg, the polarization of cellular membranes
in the path of current flow, as discussed elsewhere in this
article) may exert independent, direct effects at each of these
levels.42,74,158 Consequently, tDCS may influence neural func-
tion in the short term through bottom-up effects of neuronal and
synaptic activity, as well as by top-down effects of neuronal
network dynamics,159,160 which further constrain any additive
effects of tDCS at synapses. Moreover, because such changes
in the patterns of neural activity can be self-reinforcing,
adaptive processes following an additional disruption to
homeostasis are likely to be relevant to both the immediate and
short-term responses as well as the long(er)-term responses to
tDCS (in some cases, up to several months later).
Third, measures of the effect of tDCS are limited. Although
there is some information from electrophysiologic, imaging, and
pharmacologic studies, most data describing the effects of the
intervention are behavioral. Given the complex relationship
between behavior and function at various levels of the nervous
system, the effects of tDCS at the synaptic level may be difficult to
determine because the available measures of response (eg, on
cognition or behavior) are several levels removed from the site
of the direct effects of tDCS. A better understanding of the
mechanisms and effects of tDCS at synapses, cells, circuits, net-
works, and behavior may help in the cross-application of DR
activity occurring at different levels of hierarchical brain organi-
zation.42 However, in order to realize the potential of tDCS to
provide effective clinical treatments, alter human performance,
and/or enhance cognition, a more synthetic understanding of DR
relationships for tDCS that spans organizational levels and
mechanisms will be required. This information will also be cru-
cial to developing guidelines that can inform rational design of
tDCS applications to produce specific outcomes.
Applying the framework of hormesis to tDCS dosimetry
may be useful. In contrast to linear or linear threshold-based
DR models, which describe monotonic response past a thresh-
old dose (zero and nonzero, respectively), the hormetic DR
model describes a varying, biphasic response that only
becomes monotonic outside the dose range delineating the
adaptive response. The typical shape of hormetic DR curves
is bimodal, with upright or inverted U- or J-shapes representing
low-dose stimulation and high-dose inhibition (or vice versa).
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The stimulatory phase at the low dose range of the biphasic
hormetic DR can occur through direct stimulation or through a
compensatory response to homeostatic perturbation. Addition-
ally, hormetic DR models apply to the effects of a precondi-
tioning dose. In this light, tDCS may be considered to be
analogous to a preconditioning stimulus that modulates the
neural system’s sensitivity to subsequent effects of neuronal
activity on synaptic plasticity161 or to further exposures to
tDCS.162
Hormetic DR models were conceived in toxicology to
explain the paradoxical protective effects of very low doses of
a toxin. In that context, perturbation of a system’s homeostasis
by an agent that would be harmful at high doses instead stimu-
lates a ‘‘compensatory’’ or protective response at very low doses
(see Figure 4). As long as the effects of the stimulated ‘‘com-
pensatory’’ response exceed the magnitude of the effects of the
dose’s ‘‘direct perturbation,’’ the effect on the response is sti-
mulatory. Exceeding the optimum dose required to activate the
compensatory mechanism, the magnitude of the perturbation
(ie, the dose) then opposes stimulation of the ‘‘compensatory’’
response until a minimum response threshold is reached (ie, the
hook of the inverted ‘‘J,’’ as shown in Figure 4), beyond which
point there is no further compensation for dose perturbation of
the system; the direct effects of the perturbation simply accu-
mulate with dose (ie, the ‘‘stem’’ of the inverted ‘‘J’’).
Using this framework, the neuromodulatory effects of tDCS
can be analogously described in terms of an adaptive response,
except that the classifications of mechanisms engaging the
‘‘direct perturbation’’ versus ‘‘compensatory effect’’ are
reversed. Simply, the mechanism for DR to tDCS is the synap-
tic plasticity itself, which is an adaptive response triggered by
cumulative perturbation of ongoing neuronal activity over time
during stimulation. Mechanisms for tDCS effects still operate
within a hormetic dose range, except that it is defined by the
cumulative time of stimulation prior to the onset of neuroplas-
ticity, rather than the cessation of compensatory activity.
The effects of tDCS are reflective of hormetic effects in
several respects. First, nonlinear DRs to tDCS have been
observed in the motor system. In particular, cathodal tDCS
decreased corticospinal excitability at 1 mA but significantly
increased corticospinal excitability at 2 mA, without any
change in polarity or position of the stimulating electrodes.49
This suggests that the tDCS mechanism is active in a hormetic
response range. Second, tDCS incurs effects despite current
amplitudes incapable of directly generating a neuronal
response. This supports the possibility of a hormetic response.
Third, the magnitude of tDCS effects seems to be mostly at or
below a 50% change from baseline. Notably, hormetic
responses for integrative end points (such as cognitive func-
tion or behavior) characteristically involve a change of 30% to
60% over control. Considering this, the modest size of tDCS
effects may be simply reflective of an intrinsically adaptive
response to tDCS, rather than of ambiguity in the evidence for
a reliable effect.
Current Flow Modeling (Marom Bikson,
J. Patrick Reilly)
Although modern tDCS spans the past 15 years, the mathemat-
ical tools employed to predict current flow through biological
tissues during electrical stimulation have been in development
for decades.163-168 Over the past 7 years, increasingly sophis-
ticated models have been developed and applied to predict
brain current during tDCS,52,169-172 and these have been impor-
tant to informing and creating new neurostimulation technolo-
gies and techniques.55
Despite the growing interest in theoretical modeling and the
large number of currently completed and ongoing human trials,
there have been relatively few attempts to validate models.
Efforts thus far have included current flow validation through
scalp measurements,173 imaging,174,175 surrogate suprathres-
holds waveforms,176 and the use of in situ probes in phantom
Figure 4. Hormetic dose–response curve depicting the quantitative features of hormesis.
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skulls177 and in live primates.178 Such efforts have provided
reasonable correlations of elicited motor reactions and EMG
responses with existing computational models of peripheral
neural stimulation.179 However, retrospective and prospective
models intended to explain and validate human trials of tDCS,
providing only indirect evidence of model accuracy.55,180-184
Truly ‘‘gold standard’’ validation can be achieved through
intracranial recording in humans (for example, from patients
undergoing preoperative measurement for epilepsy treatment
with acute implants or chronic deep brain stimulation implants)
or through the use of brain probes in animal models. The design
of a practical probe to explore the 3-dimensional electric field
induced in the brain without materially affecting the field dis-
tribution requires particular attention.
Still, although precisely predicting electrical current flow
patterns through the brain is of vital importance, it is equally
crucial to develop a better understanding of how electric cur-
rent applied to the brain generates distinct patterns of neural
activity and influences cognitive processing and behavioral
effects. This requires computational models that address and
depict electrostimulation and effects of particular central neural
sites and networks. However, development of a computational
model for tDCS electrostimulation is especially challenging,
considering that the electric field induced in the brain during
tDCS is thought to be well below the threshold of excitation
predicted by conventional neural stimulation models.
Transcranial DC electrostimulation model development
should start with predicting which neural elements are acti-
vated by electrical stimulation,185 including cell types (eg,
excitatory pyramidal neurons, glia)71,115 and the extent to
which these are affected, as well as which—and to what
extent—cellular structures are affected (eg, soma, dendrites,
synaptic terminals, etc).43,186 Extant models of tDCS differ
from prior efforts in modeling electrical stimulation in an
important way—tDCS is low-intensity, producing subthreshold
polarization,43,187 whereas most modeling efforts focused on
suprathreshold stimulation that induced neuronal firing. To be
sure, further validation of present models of tDCS current flow
and the development of new models that span from current
flow to induced changes at the cellular and network levels
remain key challenges and opportunities to advance the science
of tDCS.188 We believe that a multidisciplinary approach,
employing a number of neuroscientific and neurocognitive
tools and techniques, is best suited to achieve these tasks.
Biomarkers and Imaging to Determine
Mechanisms of tDCS (Vincent P. Clark,
Emily Kappenman, Jessica Richardson)
Although some plausible hypotheses have been offered
regarding the neurobiological mechanisms leading to the
behavioral effects of brain stimulation methods such as tDCS,
its effects are still uncertain in many respects. Biomarkers,
including neuroimaging, offer the best way to identifying the
effects of tDCS and infer its underlying mechanisms. It can
also be used to guide the application of neurostimulation in
order to enhance or fine-tune its effects and to examine issues
related to its health effects and safety. A variety of different
forms of neuroimaging currently exist today. These vary by the
species tested (human vs animal), what type of information the
imaging methods provide, and the range of spatial and temporal
precision they are able to measure.
Invasive methods can be used typically on test animals or
with humans who have severe neurological disorders requiring
direct access to the brain for surgery. Although such work might
help us to understand the direction and magnitude of current
flow evoked by tDCS in the brain, much of the animal work has
been performed using parameters that are substantially different
(in terms of current density, duration, intra- vs extracranial, etc)
from what humans are administered. Such differences make it
difficult to translate these results to human tDCS mechanisms
and may also be confounded by other differences, such as head
size, skull thickness, and composition, and the effect of making
holes in the skull to insert recording instruments.
Another basic distinction is between in vitro (in an artificial
environment) and in vivo (in a living organism) neuroimaging
methods. In vitro methods require that tissue is removed and
studied outside the body. This is most often done using tissue
from experimental animals. However, human tissue can also be
obtained, either during surgery to excise diseased tissue or
postmortem. In vitro testing allows for measurements of the
activity of single neurons, even single ion channels within a
single neuron, and allows for the precise control of the excised
neuron’s environment. In previous studies, it has been used to
identify the effects of applied electrical fields on individual
neurons and has given some evidence as to the possible
mechanisms of whole brain effects of tDCS.43,71,188,189
Although informative, removing neurons from their natural
environment can alter their responses and difficulties in infer-
ring effects of tDCS at the modular, areal, network, and
regional levels from activity of single cells can lead to uncer-
tainties in how activity at these different levels are related.
There are a variety of in vivo brain imaging methods, which
can be categorized by their degree of invasiveness: (1) com-
pletely noninvasive, operating by recording energy produced
naturally by the brain and passively moved out through the skull
and scalp; (2) semi-invasive, operating by applying energy into
the brain or substances into the bloodstream; and (3) fully inva-
sive, passing recording devices through the scalp and skull
directly into the brain. Neuroimaging methods can also be cate-
gorized by what physical characteristics of the brain are detected
and recorded and what can be inferred from these measures. As
we move from less to more invasive, these methods typically go
from lower sensitivity and spatial precision to more so, but more
invasive measures also typically involve greater potential for
health-related issues and are consequently more risky to use.
Completely noninvasive methods include electroencephalo-
graphy (EEG), which measures electrical activity produced by
the nervous system, and magnetoencephalography (MEG), which
measures magnetic activity. Both are direct measures of brain
activity with submillisecond temporal resolution, making them
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especially appealing tools to combine with brain stimulation, as
they are able to follow changes in brain activity as they unfold
over time.190 This high temporal resolution provides unique infor-
mation to supplement the complementary high spatial resolution
information derived from other, more invasive techniques.
There have been a number of studies that use EEG in com-
bination with tDCS, assessing changes in neural activity fol-
lowing administration of tDCS (sequential tDCS-EEG
recordings) or assessing the changes in brain activity during
tDCS (simultaneous tDCS-EEG recordings). Most studies to
date have focused on sequential recordings, which avoid the
potential problem of artifacts induced by simultaneous tDCS-
EEG recordings (for more information, see Woods et al191). For
example, EEG has been used to infer health effects of tDCS.192
Electroencephalography and event-related signals derived from
EEG (known as event-related potentials [ERPs]) have provided
a window on the specific brain processes modulated by tDCS.
For example, EEG recordings have been used to show that
stimulation of the medial frontal cortex modulates ERP indices
of error monitoring.193 It has also been shown that tDCS
applied in short bursts can modulate slow EEG activity (<3
Hz).194 In some cases, EEG/ERP measures can be used to
observe brain-related changes in the absence of overt corre-
sponding changes in behavior, which make EEG/ERP mea-
sures particularly useful in assessing the subtle changes that
may be induced by mild electrical brain stimulation.
Another potential use of EEG is as a method of determin-
ing the optimum location for the placement of tDCS electro-
des. For example, EEG has been examined as a means of
finding the optimum electrode location for tDCS administra-
tion in the treatment of tinnitus, wherein EEG measures were
used to determine the precise location where gamma band
activity was maximal in an individual as a target for place-
ment of the cathodal electrode.195 Although in this case the
EEG-derived electrode placement provided no additional
advantages over and above the traditional electrode place-
ment in studies of tinnitus, this is a clear direction for future
research. Electroencephalography has also been used with
tACS to determine the individual alpha frequency to stimulate
in order to modulate alpha power.196
There are also studies that have combined tDCS with MEG.
Magnetoencephalography has been used to localize the effects of
tDCS when applied over primary motor or sensory cortices.197
Further, network activation and dynamics have been explored
with MEG when tDCS is applied during rest198 and during
task.199 Combining MEG with a powerful statistical approach
(independent component analysis), tDCS-induced changes
(polarity nonspecific) that outlasted the duration of the stimula-
tion were observed in resting networks.198 In Suntrup et al,199
changes in brain oscillatory behavior (as indicated by increased
event-related desynchronization power and spread) were
observed during fast and challenged, but not simple, swallow
tasks following anodal tDCS. Further, combining MEG with
sensitive filtering (ie, beamforming) during the same experiment
revealed the cortical swallowing network and important activa-
tion asymmetries in response to tDCS. Recently, MEG has also
been combined with tACS.61 Advances in filtering allowed for
investigators to determine modulations of brain oscillations
online during tACS administration for a wide range of frequen-
cies, including that at which tACS was applied. Both EEG and
MEG can also be used to measure network dynamics, which
may be especially important in understanding how current flows
through the brain beyond the portion of cortex directly under-
neath the electrodes. Electroencephalography- and MEG-
measured network dynamics may also provide an especially
useful means of determining the validity of current flow models
of tDCS (discussed more above).
Moving higher in spatial resolution and lower in temporal
resolution, a large variety of semi-invasive brain imaging
methods exist. Two frequently used methods are magnetic
resonance imaging (MRI) and positron emission tomography
(PET). Magnetic resonance imaging applies a combination of
static and fluctuating magnetic fields with radiofrequencies
designed to image the concentration and local environments
of atomic nuclei.200 The most common nuclei imaged by MRI
are hydrogen protons contained in water molecules. Depending
on the timing, frequency, and strength of applied magnetic
fields and radio waves, MRI can be used to obtain gross struc-
tural MRI (sMRI), fine structural (diffusion along white matter
pathways using diffusion tensor imaging [DTI] or diffusion
kurtosis imaging [DKI]), spectroscopic (magnetic resonance
spectroscopy [MRS]), and functional MRI (fMRI) images.
More invasive forms of sMRI and fMRI exist that use injected
gadolinium or other exogenous agents to alter local magnetic
field strengths in ways that help to enhance contrast in images.
In contrast to MRI, PET uses injection or inhalation of radio-
active tracers, which can be detected inside the body and used
to examine a variety of chemical or metabolic pathways
depending on the exact tracer substance used.201 Examples of
how these neuroimaging methods have been applied to tDCS
are summarized below.
Structural MRI can reveal the brain’s structure to millimeter
resolution, making this an ideal tool for developing models of
current flow and electrode placement202 and also for coupling
with other technologies to localize the effects of tDCS. Advanced
techniques such as DTI and DKI can even isolate specific tissues
(eg, white matter tracts) for characterization and can be used to
measure structural changes in the brain that may occur after tDCS
exposure, particularly extended use or sessions. Incorporating
DTI into electric field modeling will be important when planning
electrode placement for individuals with TBI, where often dam-
age in this population can only be visualized with DTI and not
with high resolution T1 or T2 structural images.
Structural MRI combined with finite element modeling has
also been used to estimate individual differences in current
flow with tDCS. Laakso et al203 developed head models for
24 subjects and examined individual variability in current
intensities in the brain. They found that variations in the elec-
tric fields of the hand motor cortex had a standard deviation
(SD) of approximately 20% of the mean and that cerebrospinal
fluid (CSF) thickness was the primary factor influencing an
individual’s electric field, explaining 50% of the
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interindividual variability, with a thicker layer of CSF decreas-
ing field strength at the brain surface. The next step in such
work might be to compare the magnitude of tDCS effects on
behavior with estimates of field strength and to determine
whether field strength in specific areas of the cortex is an
important predictor of tDCS effects. The long-term effects of
tDCS on brain anatomy has been studied by Zheng and
Schlaug,204 who found that daily active tDCS over motor cor-
tex, coupled with physical/occupational therapy in recovering
patients with stroke, altered FA in the cortico-tegmental-spinal
tract compared to sham. The change in FA correlated with
improved scores of motor function, suggesting that white mat-
ter structural changes may be involved in the long-term beha-
vioral effects of repeated tDCS.
A variety of published studies have used fMRI or PET to
examine changes in brain activity associated with tDCS. As 1
example, Brunelin et al205 first showed that a multiday tDCS
protocol could be used to reduce patients’ reports of auditory
and verbal hallucinations. Based on this work, Mondino et al206
showed using resting-state fMRI that the same protocol
reduced connectivity of the left temporoparietal junction and
the left anterior insula, which was correlated with reduced
hallucinations. As another example, Wang et al207 found that
tDCS over the portion of somatosensory cortex representing
the foot increased BOLD fMRI responses in that area in
response to foot stimulation. Other studies have used fMRI to
plan application of tDCS. Matsushita et al208 used prior fMRI
studies of pitch discrimination to identify regions involved in
this perceptual process and were able to reduce pitch discrimin-
ability by stimulation of this region.
A series of studies134,135,209 used BOLD fMRI to examine
the relationship between brain regions involved in learning to
detect target objects placed in complex images and the effects
of tDCS applied to these functional regions. Overall, fMRI
predicted the effects of both anodal and cathodal tDCS, sug-
gesting that fMRI may provide a good guide for determining
optimal placements for tDCS. This general result needs to be
confirmed using other cognitive tasks and other forms of neu-
roimaging to evaluate the sensitivity and specificity of this
relationship. Few arterial spin labeling (ASL) fMRI studies
have been conducted, with mixed results that are likely to be
at least partially attributable to differences in stimulation pro-
tocols. The investigations so far have focused on polarity-
specific effects and aftereffects of tDCS on brain activation,
as measured by increased or decreased cerebral blood flow
(CBF), and on the effects of tDCS on cortical network activ-
ity,210-213 which used fMRI to show changes in the stimulated
region concurrently with tDCS. These authors applied anodal
tDCS over the hand region of the precentral gyrus and showed
brain activity changes in M1, supplementary motor area, and
the contralateral parietal region.
Magnetic resonance spectroscopy is readily combined with
sMRI so that the concentration of various chemicals (metabo-
lites) within a selected voxel or brain region can be determined.
A small number of MRS studies with tDCS have been per-
formed to examine the neurochemical effects of tDCS. Rango
et al214 found an increase in myoinositol with tDCS. Stagg
et al215 demonstrated that anodal tDCS leads to statistically
significant reductions in GABA concentration relative to sham
conditions, whereas cathodal stimulation is associated with
reduced glutamatergic neuronal activity with a highly corre-
lated reduction in GABA. Clark et al145 found that anodal tDCS
produces a localized increase in glutamate and glutamine and
also in NAA under the stimulating electrode but not in the
opposite hemisphere. These changes were also correlated with
changes in within-network connectivity for brain networks
located nearby the stimulating electrode.146 This suggests that
anodal tDCS produces changes in excitatory neurotransmission
locally, which affects brain activity more broadly in turn.
A few studies have examined the effects of tDCS on PET-
derived images. One of the first and currently most highly cited
is by Lang et al,159 who found a complicated pattern of
increased and decreased activity using 15O PET with left M1
versus right frontopolar tDCS. In another example, Paquette
et al216 found that cathodal tDCS did not affect total CBF at
rest but did reduce the change in CBF related to performing a
motor task and concluded that there is an interaction of cath-
odal tDCS with activation-induced changes in regional cerebral
blood flow (rCBF), rather than an effect on resting or activated
rCBF itself. DosSantos et al217 used [11C] carfentanil to image
m-opioid receptor availability during tDCS over motor cortex in
1 patient with chronic temporomandibular joint (TMJ) pain,
which has been found to reduce pain perception. They found
reduced binding, suggesting an increase in opioid release due to
tDCS. Another PET study of tDCS effects on pain218 used 18F-
fluorodeoxyglucose, which images metabolic activity. They
found increased metabolism in the medulla, subgenual anterior
cingulate cortex, and insula and decreased metabolism in the
left DLPFC for active tDCS compared to sham, which may
help to explain some of the analgesic effects of tDCS.
In conclusion, there are a large variety of neuroimaging
methods that can be applied to the study of the effects and
mechanisms of tDCS. Recent studies have shown a variety of
effects of tDCS, but much work remains. Through the careful
and intelligent combination of neuroimaging with neurostimu-
lation, much can be learned about the mechanisms and optimi-
zation of tDCS.
The Trajectory and Tasks of Research in TES
and Its Translation to Clinical Practice
(James Giordano)
Clearly, there is evidence to support the validity and viability of
various types of tES—inclusive of tDCS—to elicit neurocog-
nitive effects that could be of value to medical and occupa-
tional settings and communities. Claims that extant results are
inconclusive or even indicative of a lack of effect(s) and/or of
effectiveness of tDCS can be countered by more stringent anal-
ysis of findings, paying particular attention and reference to
contexts of experimentation, use, conditions of test subjects,
and ecological variables.50,141,143
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Given these remaining unknowns, and increasing interest
in—if not demand for—neuromodulatory approaches by both
factions of the medical community and the general public,
there is a defensibly ethical imperative for ongoing research,
as well as prudent translational uses in clinical and perhaps
other (eg, occupational) settings. Thus, studies of efficacy and
mechanisms are certainly of benefit, but effectiveness research
is also critical. Herein lies a caveat—the ethical probity of any
such translation into clinical, occupational, and public use
demands efforts to maximize safety, which involves prepara-
tion, both (a) in advance of use to determine parameters and
protocols for best benefit and (b) during/after use to address
and mitigate any and all adverse or deleterious effects.219-223
Findings from experimental and ’’real-world’’ applications
of tES are important to develop and sustain a more meaningful
evidence base to guide the ways that these techniques and
technologies can and should be employed and those settings
and situations in which they should not. In the main, it will be
important to weigh and balance the potential benefits and
harms of commission (ie, engaging tES) and omission (ie, not
engaging/using tES).219,220,224,225 Information from the biome-
dical research, direct-to-consumer, and do-it-yourself commu-
nities suggests and supports broader use, as well as the utility
and effectiveness of tES. Some of this information may be
anecdotal and derived from case and/or case series reports, yet
it is nevertheless vital to document and follow. Essential to
such efforts is an accurate, aggregated database that details
methods (eg, device, montage(s), dosimetry, setting, etc) and
effects (eg, main effects/outcomes on specific parameters of
dependent variable(s) evaluated, collateral effects, etc), so as
to more precisely determine what works, in whom, to what end,
and under what contexts and circumstances. This would afford
a repository for harvesting raw data, data integration, and
exchange. Further, wide(r) data access and use would enable
large- and small-scale meta-analyses and systematic review(s),
in order to maximize utility and optimize results.226,227 Toward
this end, it will be crucial to evaluate the ways that current,
revised, and newly proposed frameworks and tools could be
used, modified, established, and maintained, and identify,
address, and attempt to resolve the neuroethico-legal issues and
problems that such a database—and the use or nonuse of tES in
specific circumstances and under particular conditions—may
incur. Our group remains dedicated to these tasks, opportuni-
ties, and challenges.
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